Chemoinformaics analysis of METHYL 2-[(1R,2R)-3-OXO-2-PENT-2-ENYLCYCLOPENTYL]ACETATE
| Molecular Weight | 224.3 | nRot | 5 |
| Heavy Atom Molecular Weight | 204.14 | nRig | 3 |
| Exact Molecular Weight | 224.141 | nRing | 1 |
| Solubility: LogS | -5.1 | nHRing | 0 |
| Solubility: LogP | 6.578 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 37.4519 |
| nHD | 0 | BPOL | 23.5361 |
| QED | 0.318 |
| Synth | 2.406 |
| Natural Product Likeliness | 1.316 |
| NR-PPAR-gamma | 0.837 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.843 |
| MDCK | 0.0000205 |
| BBB | 0.158 |
| PPB | 0.986891 |
| VDSS | 0.524 |
| FU | 0.0118336 |
| CYP1A2-inh | 0.242 |
| CYP1A2-sub | 0.22 |
| CYP2c19-inh | 0.146 |
| CYP2c19-sub | 0.549 |
| CYP2c9-inh | 0.274 |
| CYP2c9-sub | 0.989 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.259 |
| CYP3a4-inh | 0.122 |
| CYP3a4-sub | 0.04 |
| CL | 1.77 |
| T12 | 0.704 |
| hERG | 0.091 |
| Ames | 0.023 |
| ROA | 0.294 |
| SkinSen | 0.974 |
| Carcinogencity | 0.249 |
| EI | 0.967 |
| Respiratory | 0.959 |
| NR-Aromatase | 0.484 |
| Antiviral | Yes |
| Prediction | 0.704607 |